Symbols / RA Stock $12.59 +0.00% Brookfield Real Assets Income Fund Inc.
RA (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteBrookfield Real Assets Income Fund Inc. is a closed ended fixed income mutual fund launched and managed by Brookfield Investment Management Inc. The fund is co-managed by Schroder Investment Management North America Inc. It invests in fixed income markets of the United States. The fund primarily invests in securities and other instruments of companies, which includes real estate securities, infrastructure securities, and natural resources securities. Brookfield Real Assets Income Fund Inc. was formed on December 2, 2016 and is domiciled in the United States.
Ratings
Current target
$12.59
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2012-07-25 | main | JP Morgan | — → Neutral | $28 |
| 2012-07-24 | down | Raymond James | Strong Buy → Market Perform | — |
| 2012-07-24 | down | Morgan Stanley | Overweight → Underweight | — |
News
RSS: Latest RA news- RA Capital funds lift Parabilis Medicines (PBLS) common equity exposure - Stock Titan Mon, 15 Jun 2026 22
- Ra Capital sells $253,568 in Werewolf Therapeutics (NASDAQ:HOWL) stock - Investing.com Fri, 12 Jun 2026 00
- RA Capital adjusts Werewolf Therapeutics (HOWL) stake to 10.6% ownership - Stock Titan ue, 16 Jun 2026 00
- Karyopharm Announces $30 Million Private Placement with RA Capital - PR Newswire ue, 24 Mar 2026 07
- Price-Driven Insight from (RA) for Rule-Based Strategy - Stock Traders Daily Sat, 06 Jun 2026 11
- Brookfield Real Assets Income Fund Inc. Declares Monthly Distributions for Q2 2026 - Quiver Quantitative Fri, 27 Mar 2026 07
- RA: 10% Yield Not As Good As It Looks (NYSE:RA) - Seeking Alpha Wed, 28 Jan 2026 08
- What's Driving RA Capital's Massive Bet on Wave Life Sciences - Kavout ue, 31 Mar 2026 02
- RA Capital funds trim Werewolf Therapeutics (HOWL) stake with 678K-share sale - Stock Titan Fri, 12 Jun 2026 00
- RA | Brookfield Real Assets Income Insider Trading - Quiver Quantitative hu, 26 Mar 2026 07
- Ra capital funds acquire $7.65m in Artiva Biotherapeutics stock By Investing.com - Investing.com South Africa hu, 11 Jun 2026 23
- Nkarta (NASDAQ: NKTX) reports 37,000-share option grant tied to RA Capital - Stock Titan hu, 11 Jun 2026 20
- Parabilis Medicines (PBLS) RA Capital affiliates list sizable preferred stakes - Stock Titan ue, 09 Jun 2026 07
- RA Capital boosts Wave Life Sciences (NASDAQ: WVE) stake with 8.8M-share open-market buy - Stock Titan Mon, 30 Mar 2026 07
- H.C. Wainwright raises Immunovant stock price target on RA data - Investing.com hu, 21 May 2026 07
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
64.90
-3.87%
|
67.52
-20.45%
|
84.87
+170.84%
|
-119.82
|
| Operating Revenue |
|
64.90
-3.87%
|
67.52
-20.45%
|
84.87
+170.84%
|
-119.82
|
| Operating Expense |
|
3.02
-3.19%
|
3.12
+1.93%
|
3.06
-9.04%
|
3.37
|
| Selling General And Administration |
|
2.96
-3.30%
|
3.06
+1.78%
|
3.01
-9.35%
|
3.32
|
| General And Administrative Expense |
|
2.96
-3.30%
|
3.06
+1.78%
|
3.01
-9.35%
|
3.32
|
| Other Operating Expenses |
|
0.06
+2.59%
|
0.06
+9.96%
|
0.06
+11.65%
|
0.05
|
| Net Income |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Pretax Income |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Net Interest Income |
|
56.55
-6.13%
|
60.24
+13.72%
|
52.97
+10.06%
|
48.13
|
| Interest Expense |
|
13.12
+8.85%
|
12.05
-8.65%
|
13.19
+40.51%
|
9.39
|
| Interest Income |
|
69.67
-3.63%
|
72.29
+9.26%
|
66.17
+15.03%
|
57.52
|
| Gain On Sale Of Security |
|
2.98
+256.21%
|
-1.91
-654.08%
|
0.34
+169.78%
|
-0.49
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Net Income From Continuing Operation Net Minority Interest |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Net Income From Continuing And Discontinued Operation |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Net Income Continuous Operations |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Normalized Income |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Net Income Common Stockholders |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Diluted EPS |
|
—
|
1.18
-21.33%
|
1.50
+169.77%
|
-2.15
|
| Basic EPS |
|
—
|
1.18
-21.33%
|
1.50
+169.77%
|
-2.15
|
| Basic Average Shares |
|
—
|
54.57
+0.06%
|
54.54
-4.81%
|
57.29
|
| Diluted Average Shares |
|
—
|
54.57
+0.06%
|
54.54
-4.81%
|
57.29
|
| Diluted NI Availto Com Stockholders |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
1,061.11
-2.54%
|
1,088.72
+8.49%
|
1,003.56
-15.43%
|
1,186.60
|
| Cash And Cash Equivalents |
|
1.70
-22.00%
|
2.18
+1116.19%
|
0.18
-94.37%
|
3.19
|
| Cash Financial |
|
1.70
-22.00%
|
2.18
+1116.19%
|
0.18
-94.37%
|
3.19
|
| Receivables |
|
12.35
+3.45%
|
11.94
-5.39%
|
12.62
-25.34%
|
16.90
|
| Prepaid Assets |
|
0.02
+5.99%
|
0.02
+6.41%
|
0.02
-17.90%
|
0.02
|
| Investments And Advances |
|
1,046.68
-2.56%
|
1,074.22
+8.45%
|
990.56
-15.07%
|
1,166.31
|
| Total Liabilities Net Minority Interest |
|
265.97
-4.06%
|
277.21
+57.90%
|
175.57
-44.94%
|
318.87
|
| Payables |
|
5.33
-75.06%
|
21.36
+244.92%
|
6.19
+104.76%
|
3.02
|
| Accounts Payable |
|
4.30
-78.85%
|
20.32
+482.40%
|
3.49
+121.13%
|
1.58
|
| Other Payable |
|
1.03
-1.15%
|
1.04
-61.48%
|
2.70
+86.92%
|
1.45
|
| Long Term Debt And Capital Lease Obligation |
|
260.02
+1.70%
|
255.66
+51.10%
|
169.20
-46.38%
|
315.57
|
| Stockholders Equity |
|
795.14
-2.02%
|
811.50
-1.99%
|
828.00
-4.58%
|
867.73
|
| Common Stock Equity |
|
795.14
-2.02%
|
811.50
-1.99%
|
828.00
-4.58%
|
867.73
|
| Capital Stock |
|
957.72
-3.11%
|
988.44
-2.39%
|
1,012.69
-7.25%
|
1,091.86
|
| Common Stock |
|
957.72
-3.11%
|
988.44
-2.39%
|
1,012.69
-7.25%
|
1,091.86
|
| Share Issued |
|
55.25
+0.00%
|
55.25
-0.37%
|
55.46
-0.45%
|
55.71
|
| Ordinary Shares Number |
|
55.25
+0.00%
|
55.25
-0.37%
|
55.46
-0.45%
|
55.71
|
| Retained Earnings |
|
-162.58
+8.11%
|
-176.94
+4.20%
|
-184.69
+17.60%
|
-224.13
|
| Total Equity Gross Minority Interest |
|
795.14
-2.02%
|
811.50
-1.99%
|
828.00
-4.58%
|
867.73
|
| Total Capitalization |
|
1,055.16
-1.13%
|
1,067.16
+7.02%
|
997.20
-15.73%
|
1,183.30
|
| Invested Capital |
|
1,055.16
-1.13%
|
1,067.16
+7.02%
|
997.20
-15.73%
|
1,183.30
|
| Total Debt |
|
260.02
+1.70%
|
255.66
+51.10%
|
169.20
-46.38%
|
315.57
|
| Net Debt |
|
258.31
+1.91%
|
253.48
+49.97%
|
169.02
-45.89%
|
312.38
|
| Net Tangible Assets |
|
795.14
-2.02%
|
811.50
-1.99%
|
828.00
-4.58%
|
867.73
|
| Tangible Book Value |
|
795.14
-2.02%
|
811.50
-1.99%
|
828.00
-4.58%
|
867.73
|
| Cash Cash Equivalents And Federal Funds Sold |
|
1.70
-22.00%
|
2.18
+1116.19%
|
0.18
-94.37%
|
3.19
|
| Derivative Product Liabilities |
|
0.23
|
—
|
—
|
—
|
| Financial Assets Designatedas Fair Value Through Profitor Loss Total |
|
1,046.68
-2.54%
|
1,073.91
+8.42%
|
990.55
-15.07%
|
1,166.31
|
| Investmentin Financial Assets |
|
1,046.68
-2.56%
|
1,074.22
+8.45%
|
990.56
-15.07%
|
1,166.31
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
73.37
+2154.37%
|
-3.57
-101.36%
|
263.32
+156.04%
|
102.85
|
| Net Income From Continuing Operations |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Other Non Cash Items |
|
0.45
+103.78%
|
-11.97
-336.46%
|
-2.74
+40.58%
|
-4.62
|
| Gain Loss On Investment Securities |
|
12.73
+117.72%
|
-71.84
-140.28%
|
178.37
-29.71%
|
253.78
|
| Net Foreign Currency Exchange Gain Loss |
|
-0.04
-7809.80%
|
0.00
|
—
|
—
|
| Change In Working Capital |
|
-1.66
-110.47%
|
15.85
+169.35%
|
5.88
+125.44%
|
-23.14
|
| Change In Receivables |
|
-1.85
-371.34%
|
0.68
-84.11%
|
4.28
+164.23%
|
-6.67
|
| Change In Prepaid Assets |
|
-0.00
+0.62%
|
-0.00
-129.40%
|
0.00
+182.96%
|
-0.01
|
| Change In Accrued Expense |
|
0.21
+1075.12%
|
0.02
+116.90%
|
-0.10
-1434.26%
|
0.01
|
| Change In Payable |
|
-0.02
-100.12%
|
15.32
+796.53%
|
1.71
+110.41%
|
-16.43
|
| Change In Other Current Assets |
|
—
|
-0.17
-2086.78%
|
-0.01
+82.25%
|
-0.04
|
| Change In Other Current Liabilities |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Financing Cash Flow |
|
-73.89
-1425.82%
|
5.57
+102.09%
|
-266.33
-149.69%
|
-106.67
|
| Net Issuance Payments Of Debt |
|
5.00
-94.22%
|
86.46
+159.07%
|
-146.37
-63.74%
|
-89.39
|
| Issuance Of Debt |
|
5.00
-94.22%
|
86.46
+5201.20%
|
1.63
|
—
|
| Repayment Of Debt |
|
—
|
—
|
-148.00
|
—
|
| Long Term Debt Issuance |
|
5.00
-94.22%
|
86.46
+5201.20%
|
1.63
|
—
|
| Long Term Debt Payments |
|
—
|
—
|
-148.00
|
—
|
| Net Long Term Debt Issuance |
|
5.00
-94.22%
|
86.46
+159.07%
|
-146.37
-63.74%
|
-89.39
|
| Net Common Stock Issuance |
|
—
|
-2.54
+30.35%
|
-3.65
-103.45%
|
105.64
|
| Common Stock Payments |
|
—
|
-2.54
+59.05%
|
-6.21
|
—
|
| Common Stock Dividend Paid |
|
-78.24
+0.14%
|
-78.35
+32.64%
|
-116.31
+5.37%
|
-122.92
|
| Cash Dividends Paid |
|
-78.24
+0.14%
|
-78.35
+32.64%
|
-116.31
+5.37%
|
-122.92
|
| Repurchase Of Capital Stock |
|
—
|
-2.54
+59.05%
|
-6.21
|
—
|
| Net Other Financing Charges |
|
-0.65
|
0.00
|
0.00
|
0.00
|
| Changes In Cash |
|
-0.52
-125.89%
|
2.00
+166.57%
|
-3.01
+21.30%
|
-3.82
|
| Effect Of Exchange Rate Changes |
|
0.04
+7809.80%
|
-0.00
|
—
|
—
|
| Beginning Cash Position |
|
2.18
+1116.19%
|
0.18
-94.37%
|
3.19
-54.53%
|
7.01
|
| End Cash Position |
|
1.70
-22.00%
|
2.18
+1116.19%
|
0.18
-94.37%
|
3.19
|
| Free Cash Flow |
|
73.37
+2154.37%
|
-3.57
-101.36%
|
263.32
+156.04%
|
102.85
|
| Common Stock Issuance |
|
—
|
—
|
2.56
-97.58%
|
105.64
|
| Issuance Of Capital Stock |
|
—
|
—
|
2.56
-97.58%
|
105.64
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-05-14 View
- 42024-12-16 View
- 42024-09-18 View
- 42023-12-15 View
- 42023-09-13 View
- 42023-09-07 View
- 42023-09-06 View
- 42023-08-31 View
- 42023-01-10 View
- 42022-07-06 View
- 42022-03-08 View
- 42021-03-09 View
- 42020-06-04 View
- 42020-06-02 View
- 42020-03-27 View
- 42020-03-25 View
- 42020-03-25 View
- 42020-03-25 View
- 42020-03-25 View
- 42020-03-25 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|